Table 3 Demographics per population and subtype.
From: Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes
Training | Validation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
All | Subtype 0 | Subtype 1 | Subtype 2 | Subtype 3 | All | Subtype 0 | Subtype 1 | Subtype 2 | Subtype 3 | |
Age [mean (std)] | 70.0 (16.2) | 67.0 (16.9) | 69.2 (15.0) | 74.3 (15.5) | 73.0 (15.1) | 69.5 (16.2) | 66.2 (17.1) | 71.8 (14.9) | 73.9 (14.4) | 71.4 (14.7) |
Sex [% female) | 59.8 | 55.2 | 63.4 | 60.6 | 67.0 | 61.6 | 59.3 | 68.2 | 63.0 | 59.8 |
Smoking status [% in each category] | N: 32.7 E: 20.0 C: 3.4 U: 43.4 | N:32.8 E: 20.4 C: 3.2 U: 43.6 | N: 36.1 E: 19.4 C: 3.7 U: 40.7 | N: 30.5 E: 16.1 C: 2.6 U: 50.8 | N: 31.3 E: 27.7 C: 4.8 U: 36.1 | N: 31.7 E: 20.2 C: 4.6 U: 43.4 | N: 31.7 E: 18.3 C: 4.2 U: 45.8 | N: 31.1 E: 23.7 C: 6.5 U: 38.7 | N: 32.5 E: 20.2 C: 3.5 U: 43.9 | N: 31.9 E: 22.0 C: 5.5 U: 40.7 |
Mortality [% died] | 32.9 | 18.6 | 38.2 | 52.8 | 38.5 | 29.9 | 18.9 | 32.7 | 47.1 | 37.4 |
Days to death [mean (std)] | 125.5 (78.5) | 149.3 (64.4) | 115.4 (82.8) | 93.3 (83.7) | 116.1 (81.5) | 130.3 (76.8) | 149.1 (64.6) | 124.4 (80.4) | 101.5 (85.1) | 117.6 (81.4) |
Escalation [% escalated] | 41.1 | 22.4 | 58 | 57.7 | 48.6 | 37.6 | 25.2 | 45.5 | 55.8 | 43.0 |
Days to escalation [mean (std)] | 110.5 (83.9) | 142.4 (70.2) | 78.5 (86.8) | 84.4 (83.7) | 98.1 (85.0) | 115.5 (83.4) | 137.4 (73.9) | 101.2 (87.0) | 83.4 (86.6) | 107.1 (84.7) |
